Entities / Government agency
Therapeutic Goods Administration.
regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia
- Reports this week
- 0
- Active events
- 0
- Connections
- 39
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
Australian patients are seeking cheaper dental work in Bali, raising concerns about TGA standards for overseas dental procedures.Some support1 report
-
The Therapeutic Goods Administration is involved in discussions with the Royal Australian College of General Practitioners regarding the regulation and risks of AI tools in medical practice.Some support1 report
-
Concerns over unregulated peptide availability involving the Therapeutic Goods Administration and Dan Repacholi.Well supported3 reports
-
President of Koning speaks about regulatory milestones as Health Canada and TGA evaluate international medical device standards.Some support1 report
-
Roche Diagnostics received TGA authorization to supply pTau217 tests and is collaborating on the Asia-Pacific Centre of Excellence.Some support1 report
-
TGA-approved test trials took place in Sydney on July 1, involving Anthony Albanese, Mark Butler, Bob Carr, and Morris Iemma.Some support1 report
-
The Therapeutic Goods Administration regulates medical devices used in Australia and relies on European certification from German companies.Some support3 reports
Gone quiet
No new reports in 90+ days-
TGA findings highlighted risks discussed by AMA.Well supported4 reports
-
Iovance Biotherapeutics secured conditional approval for its drug Amtagvi in Australia, marking an expansion into high prevalence markets.Some support1 report
-
The Therapeutic Goods Administration (TGA) successfully completed an inspection of Wanbury Limited.Some support1 report
-
Owlet plans to launch its FDA-authorized Dream Sock medical wearable in Australia and New Zealand, partnering with Baby Bunting.Some support1 report
-
Strict approval processes govern market access for CBD oil products via the Therapeutic Goods Administration.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Therapeutic Goods Administration this week
News at the entities that move Therapeutic Goods Administration most-
Eli Lilly and Company TransactionalEli Lilly and Company acquired Point and established a supply agreement with EUZ.Moves Therapeutic Goods Administration
-
Australian Medical Association OperationalThe Australian Medical Association advocates for greater authority within the private health system.Moves Therapeutic Goods Administration
-
Western Australia StructuralGRDC reviewed zone ratings across Western Australia and scientists advised on pest control measures.Moves Therapeutic Goods Administration
-
South Australia StructuralA restaurant in South Australia is gaining recognition from the Michelin Guide and government support for its economic contributions.Moves Therapeutic Goods Administration
-
New South Wales OperationalTraining supports state's fire season needs in New South Wales.Moves Therapeutic Goods Administration
-
Sydney Shared contextGymea, located in Sydney, is aiming to emulate the success of Cronulla.Moves Therapeutic Goods Administration
Connections
The 10 strongest of 39, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Roche Diagnostics Structural
Roche Diagnostics is authorized by the Therapeutic Goods Administration to supply pTau217 tests.
-
Eli Lilly and Company Transactional
The TGA evaluates Eli Lilly's products, including price negotiations, to determine market access in Australia.
-
Western Australia Structural
The Therapeutic Goods Administration regulates medical devices and enforces standards for unregulated peptides within Western Australia.
-
South Australia Structural
The TGA regulates medical devices that are utilized within the operational framework of the South Australian ambulance fleet.
-
Iovance Biotherapeutics Structural
TGA granted conditional approval for Iovance Biotherapeutics' product, Amtagvi.
-
Australian Medical Association Operational
TGA findings are being used to validate and discuss risks that are already concerns of the AMA.
-
Dan Repacholi Operational
Dan Repacholi raised concerns about unregulated peptide availability, which the TGA is addressing.
-
Health Canada Mentioned together
Both bodies are peer regulatory agencies that evaluate international medical device standards.
Show all 10 connections
-
New South Wales Operational
The TGA regulates medical devices that are utilized within the NSW ambulance fleet operations.
-
Sydney Shared context
The Therapeutic Goods Administration conducts approved test trials within the jurisdiction of Sydney.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
3 events- Australian patients are seeking cheaper dental work in Bali, raising concerns about TGA standards for overseas dental procedures.
- The Therapeutic Goods Administration is involved in discussions with the Royal Australian College of General Practitioners regarding the regulation and risks of AI tools in medical practice.
- President of Koning speaks about regulatory milestones as Health Canada and TGA evaluate international medical device standards.
July 2026
4 events- TGA clearance enables clinical trial initiation for CAMP4 Therapeutics, leading to international expansion efforts.
- Roche Diagnostics received TGA authorization to supply pTau217 tests and is collaborating on the Asia-Pacific Centre of Excellence.
- TGA-approved test trials took place in Sydney on July 1, involving Anthony Albanese, Mark Butler, Bob Carr, and Morris Iemma.
- The Therapeutic Goods Administration regulates medical devices used in Australia and relies on European certification from German companies.
Show 1 earlier month
June 2026
6 events- Concerns over unregulated peptide availability involving the Therapeutic Goods Administration and Dan Repacholi.
- TGA findings highlighted risks discussed by AMA.
- Iovance Biotherapeutics secured conditional approval for its drug Amtagvi in Australia, marking an expansion into high prevalence markets.
- The Therapeutic Goods Administration (TGA) successfully completed an inspection of Wanbury Limited.
- Owlet plans to launch its FDA-authorized Dream Sock medical wearable in Australia and New Zealand, partnering with Baby Bunting.
- Strict approval processes govern market access for CBD oil products via the Therapeutic Goods Administration.